Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 22

Trial Status

Completed2

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT02043548Phase 2Completed
Tocilizumab in the Treatment of Refractory Polymyositis and Dermatomyositis
DermatomyositisPolymyositis
PrincipalinvestigatorStart date: 2014-10-01
NCT00106184Phase 2Completed
Rituximab for the Treatment of Refractory Adult and Juvenile Dermatomyositis (DM) and Adult Polymyositis (PM)
DermatomyositisJuvenile DermatomyositisMyositis+1 more
Principalinvestigator

Research Network

Collaboration Network

2 collaborators·1 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

University of Pittsburgh

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Ann M. Reed, MD

Mayo Clinic

Moderately Similar
1 trials

Shared therapeutic areas:

DermatomyositisDermatomyositis, Childhood TypeMyositis+1 more

Worked with same sponsors:

BiogenGenentech, Inc.+2 more
Collaborated on 1 trial
Similarity Score44%

Adam I Schiffenbauer, M.D.

National Institute of Environmental Health Sciences (NIEHS)

Moderately Similar
4 trials

Shared therapeutic areas:

DermatomyositisMyositisPolymyositis+1 more

Worked with same sponsors:

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Similarity Score30%

Maria Antonietta D'Agostino

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Related
3 trials

Shared therapeutic areas:

DermatomyositisPolymyositis
Similarity Score15%

Petros Efthimiou, MD

New York Presbyterian Brooklyn Methodist Hospital

Related
1 trials

Shared therapeutic areas:

DermatomyositisPolymyositis
Similarity Score15%

Manal Hassanien, professor

Assiut University

Related
2 trials

Shared therapeutic areas:

DermatomyositisPolymyositis
Similarity Score15%

Todd D Levine, MD

Phoenix Neurological Associates, LTD

Related
4 trials

Shared therapeutic areas:

DermatomyositisPolymyositis
Similarity Score15%

Carl Pepine, MD

University of Florida

Related
7 trials

Shared therapeutic areas:

DermatomyositisPolymyositis

Worked with same sponsors:

University of Pittsburgh
Similarity Score15%

Lisa G Rider, M.D.

National Institute of Environmental Health Sciences (NIEHS)

Related
4 trials

Shared therapeutic areas:

DermatomyositisPolymyositis
Similarity Score15%

Kezar

Kezar Life Sciences, Inc.

Related
4 trials

Shared therapeutic areas:

DermatomyositisPolymyositis
Similarity Score15%

Zhanguo Li

Peking University People's Hospital

Related
4 trials

Shared therapeutic areas:

Dermatomyositis
Similarity Score8%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT02043548Phase 2PrincipalInvestigator

Tocilizumab in the Treatment of Refractory Polymyositis and Dermatomyositis

DermatomyositisPolymyositis
Completed
NCT00106184Phase 2PrincipalInvestigator

Rituximab for the Treatment of Refractory Adult and Juvenile Dermatomyositis (DM) and Adult Polymyositis (PM)

DermatomyositisJuvenile DermatomyositisMyositis+1 more
Completed

All 2 trials loaded